Targeting caspase-3 as dual therapeutic benefits by rnai facilitating brain-targeted nanoparticles in a rat model of parkinson’s disease

HIGHLIGHTS

• who: Yang Liu et al. from the Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA, School of Pharmacy, Fudan University, Shanghai, People's Republic of China, Department of Life have published the paper: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease, in the Journal: PLOS ONE | www.plosone.org of May/13,/2013
• what: The hypothesis of anti-apoptotic and anti-inflammation as synergistic therapeutic benefits by down-regulating the expression and activation level of caspase-3 in brain . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.